Results 201 to 210 of about 1,240,457 (275)

Diagnostic utility of Th2 cytokines (IL-4, IL-5, IL-10, and IL-13) in pulpal blood for assessing pulpitis severity. [PDF]

BMC Oral Health
Li Q.
europepmc   +1 more source

793 Targeting engineered interleukin-2 (IL-2) to antigen specific T cells via novel biologic platforms

Journal for ImmunoTherapy of Cancer, 2021
Ronald Seidel, Natasha Girgis, Zohra Merazga, Anish Suri, John Ross, Raymond Moniz, Steve Quayle, Ahmet Vakkasoglu, Tina Daigneault, Simon Low   +9 more
doaj   +1 more source

Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis. [PDF]

BMC Neurol
Itorralba J, Brand-Arzamendi K, Saab G, Muccilli A, Schneider R.   +4 more
europepmc   +1 more source

[Biological activity and antitumor effect of long-acting recombinant human interleukin-2 drug]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Liang X, Zhang F, Jin T, Zhu J.
europepmc   +1 more source

172Ex vivo engineering of previously thawed and cryopreserved umbilical cord blood (UCB) with interleukin (IL)-2, IL-7, IL-12 and anti-CD3 for expansion of cytotoxic T lymphocytes (CTL): Promising strategy for adoptive cellular immunotherapy (ACI) post UCB transplantation (T)

, 2003
Mitchell S. Cairo, Janet Ayello, C. van de Ven   +2 more
openalex   +1 more source

Relationship between inflammatory factors, lactic acid levels, acute skin failure, bad mood, and sleep quality. [PDF]

World J Psychiatry
Liu YF, Cong W, Zhou CM, Yu Y, Zhang XJ.
europepmc   +1 more source

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2. [PDF]

Ther Adv Med Oncol
Reitmajer M, Nanz L, Müller N, Leiter U, Amaral T, Aebischer V, Flatz L, Forschner A.   +7 more
europepmc   +1 more source

SILAC-based quantification of changes in protein tyrosine phosphorylation induced by Interleukin-2 (IL-2) and IL-15 in T-lymphocytes. [PDF]

Data Brief, 2015
Osinalde N, Sánchez-Quiles V, Akimov V, Blagoev B, Kratchmarova I.   +4 more
europepmc   +1 more source

Therapy for refractory acute graft versus host disease (aGVHD) with basiliximab (BaMab) - a selective interleukin-2 receptor (IL-2R) antagonist

, 2004
V.A. Moreira, Carmem Bonfim, Marco A. Bitencourt, D.C. Setubal, Cláudia Santos Lorenzato, Juan Carlos García‐Ruiz, J. Zanis-Netto, Carlos Roberto de Medeiros, Ricardo Pasqüini   +8 more
openalex   +1 more source